(ENTR) |
| 0 (0%) 05-29 15:06 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | |
| 52w Low: |
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Fri, 29 May 2026
'It's unfair you can't do everything here': Education comes with exile in Martinique - France 24
Tue, 26 May 2026
CATS to Open at William G Skaff Center With Entr'Acte Theatrix - BroadwayWorld
Thu, 21 May 2026
Amsterdam’s first VR museum opens its doors today - NL Times
Sun, 17 May 2026
Cowbois a'r Gerddorfa - BBC National Orchestra of Wales - BBC
Thu, 07 May 2026
Entrada emphasises DMD therapy's safety as dystrophin data disappoint - FirstWord Pharma
Thu, 07 May 2026
Entrada Therapeutics to Announce Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study on May 7, 2026 - The Manila Times
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
